BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9067327)

  • 1. Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate.
    Rho JM; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1383-91. PubMed ID: 9067327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons.
    Rho JM; Donevan SD; Rogawski MA
    J Physiol; 1996 Dec; 497 ( Pt 2)(Pt 2):509-22. PubMed ID: 8961191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors.
    Rho JM; Donevan SD; Rogawski MA
    Ann Neurol; 1994 Feb; 35(2):229-34. PubMed ID: 8109904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Felbamate block of the N-methyl-D-aspartate receptor.
    Subramaniam S; Rho JM; Penix L; Donevan SD; Fielding RP; Rogawski MA
    J Pharmacol Exp Ther; 1995 May; 273(2):878-86. PubMed ID: 7752093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Felbamate inhibits [3H]t-butylbicycloorthobenzoate (TBOB) binding and enhances Cl- current at the gamma-aminobutyric AcidA (GABAA) receptor.
    Kume A; Greenfield LJ; Macdonald RL; Albin RL
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1784-92. PubMed ID: 8667250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Felbamate is a subunit selective modulator of recombinant gamma-aminobutyric acid type A receptors expressed in Xenopus oocytes.
    Simeone TA; Otto JF; Wilcox KS; White HS
    Eur J Pharmacol; 2006 Dec; 552(1-3):31-5. PubMed ID: 17056029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use-dependent inhibition of the N-methyl-D-aspartate currents by felbamate: a gating modifier with selective binding to the desensitized channels.
    Kuo CC; Lin BJ; Chang HR; Hsieh CP
    Mol Pharmacol; 2004 Feb; 65(2):370-80. PubMed ID: 14742679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration.
    Taylor LA; McQuade RD; Tice MA
    Eur J Pharmacol; 1995 Apr; 289(2):229-33. PubMed ID: 7621896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felbamate and meprobamate: a comparison of their anticonvulsant properties.
    Frey HH; Bartels I
    Epilepsy Res; 1997 Jun; 27(3):151-64. PubMed ID: 9237049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit.
    Harty TP; Rogawski MA
    Epilepsy Res; 2000 Mar; 39(1):47-55. PubMed ID: 10690753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.
    Grauert M; Rho JM; Subramaniam S; Rogawski MA
    J Pharmacol Exp Ther; 1998 May; 285(2):767-76. PubMed ID: 9580625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the antiepileptic drug felbamate on long-term potentiation in the CA1 region of rat hippocampal slices.
    Pugliese AM; Corradetti R
    Neurosci Lett; 1996 Aug; 215(1):21-4. PubMed ID: 8880744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors.
    Kumar M; Dillon GH
    Eur J Pharmacol; 2016 Mar; 775():149-58. PubMed ID: 26872987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felbamate displays in vitro antiepileptic effects as a broad spectrum excitatory amino acid receptor antagonist.
    Domenici MR; Sagratella S; Ongini E; Longo R; Scotti de Carolis A
    Eur J Pharmacol; 1994 Dec; 271(2-3):259-63. PubMed ID: 7705426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
    Pistis M; Belelli D; Peters JA; Lambert JJ
    Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
    Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
    J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felbamate selectively blocks in vitro hippocampal kainate-induced irreversible electrical changes.
    Longo R; Domenici MR; Scotti de Carolis A; Sagratella S
    Life Sci; 1995; 56(21):PL409-14. PubMed ID: 7537844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of felbamate, kynurenic acid derivatives and NMDA antagonists on in vitro kainate-induced epileptiform activity.
    Domenici MR; Marinelli S; Sagratella S
    Life Sci; 1996 May; 58(26):PL391-6. PubMed ID: 8691980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies.
    Gonzalez LA; Gatch MB; Taylor CM; Bell-Horner CL; Forster MJ; Dillon GH
    J Pharmacol Exp Ther; 2009 May; 329(2):827-37. PubMed ID: 19244096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anesthetic and convulsant barbiturates alter gamma-aminobutyric acid-stimulated chloride flux across brain membranes.
    Allan AM; Harris RA
    J Pharmacol Exp Ther; 1986 Sep; 238(3):763-8. PubMed ID: 2427687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.